“…Previous in vitro work has suggested that recombinant arrestin can stabilize Meta II, block the Meta III formation, or shift the Meta II/III equilibrium toward Meta II and inhibit the overall rate of all-trans retinal release (Sommer and Farrens, 2006). However, other findings instead suggest the stabilization of Meta III by either full-length arrestin (Burns et al, 2006) or its truncated form, Arr Tr , which is similar to physiologically relevant splice variant p44 (Chatterjee et al, 2015). A major caveat of these biochemical experiments is that they were performed with either detergent-solubilized rhodopsin or purified rod outer segment membranes, in which concentrations of added protein components (and the overall metabolic state of the system) are substantially different from those in intact cells.…”